Canopy Growth: Analysts Expect Q2 Revenues Of $142.5 Million

Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) announced that they will be reporting their fiscal second quarter financials before market open on November 5th.

Analysts have a consensus C$26.94 12-month price target on the company, via a total of 14 analysts, with 2 analysts having buy ratings, 11 have holds and 1 analyst has a strong sell rating on the stock. Nine analysts have a hold rating and two analysts have a strong sell rating. The street high comes from MKM Partners with a C$51 price target, and the lowest target comes from Stifel-GMP with a C$15 price target.

13 analysts have revenue estimates for the second quarter. The mean between all 13 is C$142.49 million; this number has been revised downwards from C$191.25 million at the start May. The street high is C$173.10 million while the lowest sits at C$130 million.

Six analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 21.42%, with this number being revised downwards from 34.30% at the start of May. Street high goes to CIBC Capital Markets with a 26.50% estimate and the lowest sits at 16%.

Onto EBITDA estimates, there are currently 12 analysts who have second quarter EBITDA estimates. The mean is currently (C$52.35) million, with this number being lower at the start of May. Street high goes to Benchmark with a (C$36) million EBITDA estimate and the lowest being a (C$67.3) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Medipharm Labs Sees Canaccord Drop Price Target To $0.75

On May 17th, MediPharm Labs (TSX: LABS) Labs reported their first-quarter financials. The company announced...

Tuesday, May 18, 2021, 05:32:00 PM

Bombardier: TD, Veritas Raise Price Target, BMO Cuts

Last week, Bombardier (TSX: BBD.b) reported second quarter 2020 financials, reporting $2.7 billion in revenues...

Monday, August 10, 2020, 02:12:00 PM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Canopy Growth: Klein’s Annual Compensation Includes Base Salary of US$975k

This week, Canopy Growth Corp (TSX: WEED) (NYSE: CGC) filed for the first time a...

Tuesday, June 2, 2020, 05:07:15 PM

BMO Lifts IAMGOLD Price Target To US$3.25 Following Board Rework

On February 14th, BMO Capital Markets upgraded IAMGOLD Corporation (TSX: IMG) from market perform to...

Sunday, February 20, 2022, 01:33:00 PM